1 The effects of intracisternal (i.c.) application of putative 5-hydroxytryptamine (5-HT)lA antagonists on the reflex bradycardia evoked by injection of phenylbiguanide (i.v.) were investigated in anaesthetized, atenolol-pretreated rats. 2 Intracisternal application of spiperone (100ugkg-1) reversibly attenuated the reflex bradycardia whilst the same dose given i.v. had no effect. The bradycardia was also attenuated by i.c. methiothepin (200 pgkg-1), (±)-pindolol (lOOpugkg-1) and buspirone (200pygkg-1) but was not attenuated by antagonists selective for ax-adrenoceptors (alfuzosin; lOOpgkg-1), 5-HT2-receptors (BW 501C67; lOOpgkg-') or dopamine D2-receptors ((-)-sulpiride; lOOpgkg-) given i.c.3 It is concluded that the 5-HTlA-receptor antagonist action of intracisternally applied spiperone, methiothepin, (±)-pindolol and buspirone is responsible for the ability of these drugs to attenuate reversibly the excitation of cardiac vagal motoneurones caused by activation of the von Bezold-Jarisch reflex.
ResumoObjetivo: Avaliar a ocorrência de síndrome metabólica (SM) e fatores de risco associados em adolescentes de Vitória (ES). Métodos:Foram avaliados 380 adolescentes de 10 a 14 anos de idade estudantes de escolas públicas. Foram mensurados: índice de massa corporal, pressão arterial em repouso, dosagens séricas em jejum das concentrações de colesterol total, LDL-colesterol, HDL-colesterol, triglicerídeos e glicose.Resultados: Identificou-se prevalência de sobrepeso em 9,6% dos meninos e em 7,4% das meninas, enquanto que obesidade foi observada em 6,2 e 4,9%, respectivamente. As concentrações de triglicerídeos foram limítrofes ou altas em 6,8 e 3,4% dos meninos e em 11,8 e 5,9% das meninas. A concentração de HDL-colesterol estava abaixo dos níveis padronizados em 8,5% dos meninos e em 9,9% das meninas. A pressão arterial em repouso foi limítrofe para 5,1% dos meninos e 7,9% das meninas, enquanto que 3,4% tanto dos meninos quanto das meninas foram considerados hipertensos. Glicemia de jejum foi alta em 0,6% dos meninos e em 0,5% das meninas. No grupo estudado, 2,8% dos meninos e 2,5% das meninas apresentaram dois fatores de risco associados a SM. A prevalência de SM foi de 1,1% para meninos e 1,5% para meninas e a total foi de 1,3%. Conclusões:Fatores de risco cardiovasculares associados a SM são condições clínicas importantes nessa faixa etária. Um número significativo de adolescentes apresentou resultados limítrofes, os quais podem aumentar a prevalência de SM ou de fatores de risco independentes em curto prazo. Mais investimentos devem ser feitos na prevenção primária, considerando que o diagnóstico precoce é uma questão de fundamental importância. J Pediatr (Rio J). 2009;85(1):55-60:Síndrome metabólica, adolescentes, fatores de risco cardiovasculares, colesterol, obesidade. AbstractObjective: To evaluate the occurrence of metabolic syndrome (MS) and independent associated risk factors in adolescents in the city of Vitória, Brazil. Methods:We assessed 380 adolescents aged 10 to 14 years attending public schools. Body mass index and blood pressure at rest were measured. Fasting plasma concentrations of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides and glucose were also obtained. Results:The prevalence of overweight was 9.6% for boys and 7.4% for girls, while obesity was found in 6.2 and 4.9%, respectively. Triglyceride concentrations were borderline or high in 6.8 and 3.4% of the boys and in 11.8 and 5.9% of the girls. HDL-cholesterol was below recommended levels in 8.5% of the boys and in 9.9% of the girls. Blood pressure at rest was borderline for 5.1% of the boys and 7.9% of the girls, while 3.4% of both boys and girls were hypertensive. Fasting glycemia was high in 0.6% of the boys and in 0.5% of the girls. In the group studied, 2.8% of the boys and 2.5% of the girls had two risk factors associated with MS. Prevalence of MS was 1.1% for boys and 1.5% for girls, and overall prevalence was 1.3%. Conclusions:MS and associated cardiovascular risk factors are serious clinical conditions in...
We determined the effects of helium-neon (He-Ne) laser irradiation on wound healing dynamics in mice treated with steroidal and nonsteroidal anti-inflammatory agents. Male albino mice, 28-32 g, were randomized into 6 groups of 6 animals each: control (C), He-Ne laser (L), dexamethasone (D), D + L, celecoxib (X), and X + L. D and X were injected im at doses of 5 and 22 mg/kg, respectively, 24 h before the experiment. A 1-cm long surgical wound was made with a scalpel on the abdomens of the mice. Animals from groups L, D + L and X + L were exposed to 4 J (cm 2 ) -1 day -1 of He-Ne laser for 12 s and were sacrificed on days 1, 2, or 3 after the procedure, when skin samples were taken for histological examination. A significant increase of collagen synthesis was observed in group L compared with C (168 ± 20 vs 63 ± 8 mm 2 ). The basal cellularity values on day 1 were: C = 763 ± 47, L = 1116 ± 85, D = 376 ± 24, D + L = 698 ± 31, X = 453 ± 29, X + L = 639 ± 32 U/mm 2 . These data show that application of L increases while D and X decrease the inflammatory cellularity compared with C. They also show that L restores the diminished cellularity induced by the anti-inflammatory drugs. We suggest that He-Ne laser promotes collagen formation and restores the baseline cellularity after pharmacological inhibition, indicating new perspectives for laser therapy aiming to increase the healing process when anti-inflammatory drugs are used.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.